![](https://investorshub.advfn.com/uicon/170585.png?cb=1715106542)
Wednesday, March 18, 2020 10:31:17 PM
(second largest shareholder, and co-founder of the mega billion dollar Carlyl group),
head of the Trust fund that controls the UPennMed patents
and Dr. Fountain about dragging out some promising related tech off the shelf of the UPennMed Patents (must 50,000+ of them to drool over) from prior what if work on Corona-virus vacines, and NIH/CDC about a rush US Gov grant to rush test a UPennMed prior research project for use in immediate trials for COVID19.
We would not know till the PR dropped and the stock price gaped up in minutes to a dime before folks figured out what was going on.
No time to be on the MILV fence with all these folks on the Same #NFL Super Bowl Pharmaceutical Biotech birth team as Larry Kubin and Michael Fountain, and Dr Coven, and possibly Dr. Dorsey at UpennMed.
I think I just talked my self into buying another million $MILV shares.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM